Liu Kai, Lei Xue-Zhong, Zhao Lian-San, Tang Hong, Liu Li, Feng Ping, Lei Bing-Jun
Division of Molecular Biology of Infectious Diseases, Key Laboratory of Biotherapy of Human Disease, Ministry of Education, West China Hospital of Sichuan University, Chengdu 610041, Sichuan Province, China.
World J Gastroenterol. 2005 Mar 7;11(9):1369-72. doi: 10.3748/wjg.v11.i9.1369.
To study the expression profiles of HBsAg, HBcAg, p21WAF1/CIP1 (p21), Rb genes in hepatocellular carcinoma (HCC) and to investigate their roles in the hepatocar-cinogenesis.
HCC tissue microarray containing 120-min tissues of 40 HCC cases was constructed. HBsAg, HBcAg, p21 and Rb proteins were immunohistochemically stained by streptavidin-peroxidase conjugated method (S-P). The expression loss of these genes in cancerous, para-cancerous tissues and adjacent normal liver tissues of 40 HCCs were comparatively examined.
The positive rate of HBsAg expression in cancerous tissues of 40 HCCs was 7.5%, which was lower than that in para-cancerous and adjacent normal liver tissues (chi2 =12.774, P < 0.01; chi2 = 18.442, P < 0.01). The positive rate of HBcAg expression in cancerous tissues of 40 HCCs was 20.0%, which was also lower than that in para-cancerous and adjacent normal liver tissues (chi2 = 9.482, P < 0.01; chi2 = 14.645, P < 0.01). p21 protein deletion rate in cancerous tissues of 40 HCCs was 27.5%, which was higher than that in para-cancerous and adjacent normal liver tissues (chi2 = 7.439, P < 0.01; chi2 = 11.174, P < 0.01). p21 protein deletion correlated remarkably with the pathological grade of HCC (chi2 = 0.072, P < 0.05). Rb protein deletion rate in cancerous tissues of 40 HCCs was 42.5%, which was also higher than that in para-cancerous and adjacent normal liver tissues (chi2 = 10.551, P < 0.01; chi2 = 18.353, P < 0.01). Rb protein deletion rate did not correlate remarkably with tumor size or pathological grade of HCC (chi2 = 0.014, P > 0.05; chi2 = 0.017, P > 0.05).
Expression deletion of HBsAg, HBcAg, p21 and Rb proteins in HCCs may play important roles in the carcinogenesis of HCC. Tissue microarray is an effective high-throughput technique platform for cancer research.
研究乙型肝炎表面抗原(HBsAg)、乙型肝炎核心抗原(HBcAg)、p21WAF1/CIP1(p21)、视网膜母细胞瘤(Rb)基因在肝细胞癌(HCC)中的表达谱,并探讨它们在肝癌发生中的作用。
构建包含40例HCC患者120个组织的HCC组织芯片。采用链霉亲和素-过氧化物酶偶联法(S-P)对HBsAg、HBcAg、p21和Rb蛋白进行免疫组织化学染色。比较检测40例HCC癌组织、癌旁组织及邻近正常肝组织中这些基因的表达缺失情况。
40例HCC癌组织中HBsAg表达阳性率为7.5%,低于癌旁组织和邻近正常肝组织(χ2 = 12.774,P < 0.01;χ2 = 18.442,P < 0.01)。40例HCC癌组织中HBcAg表达阳性率为20.0%,也低于癌旁组织和邻近正常肝组织(χ2 = 9.482,P < 0.01;χ2 = 14.645,P < 0.01)。40例HCC癌组织中p21蛋白缺失率为27.5%,高于癌旁组织和邻近正常肝组织(χ2 = 7.439,P < 0.01;χ2 = 11.174,P < 0.01)。p21蛋白缺失与HCC病理分级显著相关(χ2 = 0.072,P < 0.05)。40例HCC癌组织中Rb蛋白缺失率为42.5%,也高于癌旁组织和邻近正常肝组织(χ2 = 10.551,P < 0.01;χ2 = 18.353,P < 0.01)。Rb蛋白缺失率与HCC肿瘤大小或病理分级无显著相关性(χ2 = 0.014,P > 0.05;χ2 = 0.017,P > 0.05)。
HCC中HBsAg、HBcAg、p21和Rb蛋白的表达缺失可能在HCC的发生中起重要作用。组织芯片是一种有效的高通量癌症研究技术平台。